Table 1.
Comparison of the CAR T cell generations.
| Generations | Main cytoplasmic domains | Co-stimulatory domain | Drawback |
|---|---|---|---|
| 1st generation | A single CD3 ζ-chain | None | Failure to produce adequate IL-2, low cell proliferation, higher toxicities, and brief in vivo persistence |
| 2nd generation | CD3 ζ-chain | CD28 for dual signaling | CAR T cell exhaustion |
| 3rd generation | CD3 ζ-chain | CD28 and 4-1BB | Adapted persistence and proliferation yet no enhanced efficacy as compared to earlier generations |
| 4th generation | CD3 ζ-chain | CD28 and IL-12 inducer domain | Off-target/off-tumor toxicity |
| 5th generation | CD3 ζ-chain | Cytoplasmic IL-2 receptor β-chain domain activating antigen-mediated JAK/STAT pathway | Not yet approved Preoccupied with concerns on immunogenicity and high costs |